Evaluation of L-3-[123I]iodo-α-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: A comparative study with stereotactic biopsy

European Journal of Nuclear Medicine

Volumn 26, Issue 2, 1999, Pages 144-151

  Bader, Jochen B ^a   Samnick, Samuel ^a   Moringlane, Jean Richard ^a   Feiden, Wolfgang ^a   Schaefer, Andrea ^a   Kremp, Stefanie ^a   Kirsch, Carl Martin ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Fluorine 18 fluorodeoxyglucose; Grading; L 3 123I iodo methyltyrosine; Recurrent glioma

Indexed keywords

AMINO ACID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; IODINE 123; METIROSINE;

ADULT; AGED; AMINO ACID TRANSPORT; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; CANCER GRADING; CLINICAL ARTICLE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; FOLLOW UP; GLIOMA; GLUCOSE METABOLISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; POSITRON EMISSION TOMOGRAPHY; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOTAXIC SURGERY; TUMOR RECURRENCE;

ADULT; AGED; ASTROCYTOMA; BIOPSY; BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; GLIOMA; HUMANS; IODINE RADIOISOTOPES; MALE; METHYLTYROSINES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OLIGODENDROGLIOMA; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

BIOPSY; BRAIN; CAMERAS; FLUORINE; IMAGE SEGMENTATION; PARTICLE BEAMS; PATIENT TREATMENT; POSITRON EMISSION TOMOGRAPHY; TUMORS;

BRAIN TUMORS; FLUORINE-18; FLUORINE-18 FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; L-3-[ 123I]IODO-Α-METHYLTYROSINE; RECURRENT GLIOMAS; SINGLE PHOTON EMISSION TOMOGRAPHIES; SINGLE-PHOTON EMISSION TOMOGRAPHY; STEREOTACTIC BIOPSIES;

GRADING;

EID: 0032996415     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050370     Document Type: Article

References (31)

1. Niedermeyer I, Kolles H, Feiden W. Histologic and morphometric grading of gliomas. A comparative survival analysis. Anal Quant Cytol Histol 1997; 19: 301-310.
2. Earle KM, Rentschiler HE, Snodgrass SR. Primary intracranial neoplasms: prognosis and classification of 513 verified cases. J Neuropathol Exp Neurol 1957; 16: 321-331.
3. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamato R, Kramer S, Weinstein A, Nelson JS, Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy in the multidisciplinary management of malignant gliomas: a joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology study. Cancer 1983; 52: 997-1007.
4. Wagner W, Schüller P, Willich N, Schober O, Pavlovic S, Morgenroth C, Bartenstein P, Prott EJ, Niewöhner U. Intraoperative Strahlentherapie (IORT) maligner Hirntumouren: Strahlenther Onkol 1995; 171: 154-164.
5. Chandrasoma PT, Smith MM, Apuzzo MJ. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery 1989; 24: 160-165.
6. Feiden W, Steude U, Bise K, Gündisch O. Accuracy of stereotactic brain tumour biopsy: comparison of the histologic findings in biopsy cylinders and resected tumour tissue. Neurosurgery Rev 1991; 14: 51-56.
7. Revesz T, Scaravilli F, Coutinho L, Cockburn H, Sacares P, Thomas D. Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique. Brain 1993; 116: 781-793.
8. 18F]fluorodeoxyglucose in brain tumours: a powerful diagnostic and prognostic tool. Invest Radiol 1986; 22: 360-371.
9. Alavi J, Alavia A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 1988; 62: 1074-1078.
10. Byrne TN. Imaging of gliomas. Semin Oncol 1994; 21: 162-171.
11. Leeds NE, Jackson EF. Current imaging techniques for the evaluation of brain neoplasms. Curr Opin Oncol 1994; 6: 254-261.
12. Phelps M, Huang S, Hoffman E, Selin C, Sokoloff L, Kuhl D. Tomographic measurement of local cerebral glucose metabolic rate in humans with [F-18] 2-fluoro-2-deoxy-D-glucose: Validation of the method. Ann Neurol 1979; 5: 371-388.
13. Strauss L, Conti P. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623-648.
14. 18F fluorodeoxyglucose and postitron emission tomography. Neurology 1982; 32: 1323-1329.
15. Ell P. Brain tumour uptake of iodo-alpha-methy-tyrosine. J Nucl Med 1991; 32: 2193.
16. 123I] iodo-α-methyltyrosine: competition with natural L-amino acids. J Nucl Med 1991; 32: 1225-1229.
17. Lee J, Kim D, Lee J, Chang J, Park C. Indium-111-pentreotide imaging in intra-axial tumours: comparison with thallium-201 SPET and MRI. J Nucl Med 1995; 36: 537-541.
18. Rollins N, Lowry P, Shapiro K. Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumours. Pediatr Neurosurg 1995; 22: 8-14.
19. 124IMT and first clinical results. J Nucl Med 1990;31:281-286.
20. Black K, Hawkins R, Kim K, Becker D, Lerner C, Marciano D. Use of thallium-201 SPET to quantitate malignancy grade of gliomas. J Neurosurg 1989; 71: 342-346.
21. Conti P, Bading J, Wong D, Gelbard A, Dannals R, La France N, Laughlin J, Wagner H. Positron emitting radiotracers: potential aids in the diagnosis and management of neoplasms. Tumor Diagn Ther 1988; 9: 175-176.
22. Daumas-Duport C. Histological grading of gliomas. Curr Opin Neurol Neurosurg 1992; 5: 924-931.
23. Kleihues P, Burger P, Scheithauer B. Histological typing of tumours of the central nervous system. Berlin Heidelberg New York: Springer, 1993.
24. Trivedi MA, Carnochan P. An improved synthetic procedure for L-3-iodo-α-methyltyrosine suitable for preparation in kit form. J Lab Comp Radiopharm 1993; 33: 61-64.
25. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; NS-26/2: 2780-2789.
26. Weckesser M, Grießmeier M, Schmidt D, Sonnenberg F, Ziemons K, Kemna L, Holschbach M, Langen KJ, Müller-Gärtner HW. Iodine-123 α-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent. Eur J Nucl Med 1998; 25: 150-156.
27. Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, Samnick S, Maasjosthusmann U, Lerch H, Gildehaus FJ, Wassmann H, Schober O. Uptake of iodine-123-I-α-methyl tyrosine by primary brain tumours and non-neoplastic brain lesions. Eur J Nucl Med 1996; 23: 1345-1353.
28. Weber W, Bartenstein P, Gross M, Kinzel D, Daschner H, Feldmann H, Reidel G, Ziegler S, Lumenta C, Molls M, Schwaiger M. Fluorine-18-FDG PET and iodine-123-IMT SPET in the evaluation of brain tumors. J Nucl Med 1997; 38: 802-808.
29. Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, Schäfers M, Wassmann H, Schober O. Influence of size of region of interest on the measurement of uptake of iodine-123-I-(α-methyl tyrosine by brain tumours. Nucl Med Commun 1996; 17: 609-615.
30. Tyler JL, Diksic M, Villemure JG, et al. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 1987; 28: 1123-1133.
31. 18F-deoxyglucose. Eur J Nucl Med 1997; 4: 428-434.